喹诺酮类和大环内酯类：在呼吸道感染中的作用
Quinolones and macrolides: roles in respiratory infections.
作者信息
Khan F A
机构信息
State University of New York, Stony Brook Health Sciences Center School of Medicine, N.Y.
出版信息
Hosp Pract (Off Ed). 1993 Jan 15;28(1):149-153, 156-62. doi: 10.1080/21548331.1993.11442744.
Abstract
Newer agents in these classes can be useful when standard antibiotics may be contraindicated or ineffective. They are well tolerated gastrointestinally and have excellent tissue penetration when given orally, allowing shorter courses at lower dosages. Quinolones are especially effective against nosocomial infections, macrolides against community-acquired infections.
摘要
当标准抗生素可能禁忌使用或无效时，这些类别的新型药物可能会有用。它们在胃肠道耐受性良好，口服时具有出色的组织穿透力，允许以较低剂量进行更短疗程的治疗。喹诺酮类药物对医院感染特别有效，大环内酯类药物对社区获得性感染有效。
相似文献
1
Quinolones and macrolides: roles in respiratory infections.喹诺酮类和大环内酯类：在呼吸道感染中的作用
Hosp Pract (Off Ed). 1993 Jan 15;28(1):149-153, 156-62. doi: 10.1080/21548331.1993.11442744.
2
Have we reached the point of no return? The hidden impact of antibacterial resistance in respiratory tract infection. Introduction.
Respir Med. 2001 Jun;95 Suppl A:S2-4; discussion S26-7. doi: 10.1016/s0954-6111(01)90021-6.
3
Advances in the macrolides and quinolones.大环内酯类和喹诺酮类药物的进展
Infect Dis Clin North Am. 1998 Sep;12(3):647-70. doi: 10.1016/s0891-5520(05)70203-8.
4
A guide to the treatment of lower respiratory tract infections.下呼吸道感染治疗指南
Drugs. 1995 Jul;50(1):62-72. doi: 10.2165/00003495-199550010-00006.
5
New and future antibiotics in the treatment of acute respiratory tract infections.用于治疗急性呼吸道感染的新型及未来抗生素
Thorax. 1995 Mar;50(3):223-4. doi: 10.1136/thx.50.3.223.
6
[In vitro comparative activity of moxifloxacin and other antimicrobials against respiratory pathogens].[莫西沙星与其他抗菌药物对呼吸道病原体的体外比较活性]
Rev Med Chil. 2000 Dec;128(12):1319-26.
7
Quinolones in the treatment of lower respiratory tract infections in adult patients.
Drugs. 1993;45 Suppl 3:91-7. doi: 10.2165/00003495-199300453-00016.
8
The clinical problems of bacterial resistance to the new quinolones.
J Antimicrob Chemother. 1990 Oct;26 Suppl B:207-13. doi: 10.1093/jac/26.suppl_b.207.
9
The Alexander Project: using in-vitro susceptibility data for choosing empirical therapy in LRTI.
J Antimicrob Chemother. 1996 Jul;38 Suppl A:155-70. doi: 10.1093/jac/38.suppl_a.155.
10
[Recent drug administration methods for respiratory infections].[呼吸道感染的近期给药方法]
Nihon Naika Gakkai Zasshi. 1991 May 10;80(5):675-80.
引用本文的文献
1
Intracellular concentrations of antibacterial agents and related clinical implications.抗菌药物的细胞内浓度及其相关临床意义。
Clin Pharmacokinet. 1994 Jul;27(1):63-84. doi: 10.2165/00003088-199427010-00006.
Zotero 插件